Smad6 Suppresses TGF-β-Induced Growth Inhibition in COLO-357 Pancreatic Cancer Cells and Is Overexpressed in Pancreatic Cancer
- 1 February 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 255 (2) , 268-273
- https://doi.org/10.1006/bbrc.1999.0171
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressorGenes & Development, 1998
- TGF-β signalling from cell membrane to nucleus through SMAD proteinsNature, 1997
- Smad6 inhibits signalling by the TGF-β superfamilyNature, 1997
- Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signallingNature, 1997
- Vascular MAD s: Two novel MAD -related genes selectively inducible by flow in human vascular endotheliumProceedings of the National Academy of Sciences, 1997
- The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ SignalingCell, 1997
- Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survivalGastroenterology, 1993
- Transforming growth factor-beta: recent progress and new challenges.The Journal of cell biology, 1992
- Pancreatic CarcinomaNew England Journal of Medicine, 1992